Can AI find the right antibody for a drug target? ImmunitoAI thinks so
Developing antibody drugs begins with finding an antibody that can attach to a specific spot, known as an epitope, on a protein linked to a disease. Finding an antibody that fits that spot can be difficult.
Via YourStory
Bengaluru-based immunitoAI is using artificial intelligence to tackle this problem. Its platform, AbInitio, designs antibodies for a chosen target and epitope, which the startup then tests in its own lab.
Founded in 2020 by Dr Aridni Shah and Trisha Chatterjee, the startup began when the two met in August that year through Entrepreneur First, a talent accelerator where individuals look for potential co-founders.
Shah, the CEO, holds a PhD in biological sciences from NCBS-TIFR and a bachelor’s degree in biomedical…
Courtesy
This story was originally published by YourStory. All rights belong to the original publisher.
Read the original on yourstory.com ↗